Market Tracker

02/20 3:38am ET

Emergent BioSolutions Inc (NYSE:EBS)

30.39
Delayed Data
As of Feb 17
 -0.54 / -1.75%
Today’s Change
24.47
Today|||52-Week Range
41.91
-7.46%
Year-to-Date
No recent news for Emergent BioSolutions Inc.

Today’s Trading

Previous close30.93
Today’s open30.77
Day’s range29.65 - 30.81
Volume248,407
Average volume (3 months)460,844
Market cap$1.2B
Dividend yield--
Data as of 4:02pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+60.23%
Earnings growth (this year)-40.07%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)+16.14%
P/E ratio31.0
Price/Sales3.62
Price/Book1.81

Competitors

 Today’s
change
Today’s
% change
DERMDermira Inc+0.60+1.81%
AXONAxovant Sciences Ltd+0.05+0.41%
ALDRAlder Biopharmaceuti...-0.10-0.43%
ACORAcorda Therapeutics ...0.000.00%
Data as of 4:00pm ET, 02/17/2017

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)$0.45
Annual revenue (last year)$522.8M
Annual profit (last year)$62.9M
Net profit margin12.03%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Class III Director
Daniel J. Abdun-Nabi
CFO, Treasurer &
EVP-Corporate Services
Robert G. Kramer
Corporate headquarters
Gaithersburg, Maryland

Forecasts